Vitamin D receptor BsmI haplotype BB confers lower 25(OH)D levels during tuberculosis: a pilot cross-sectional study
Therapeutic Advances in Infectious Disease
Published online on June 30, 2026
Abstract
Therapeutic Advances in Infectious Disease, Volume 13, January-December 2026.
Background:Adequate micronutrient absorption remains key for tuberculosis control.Objective:To evaluate the frequency of vitamin D receptor polymorphisms,FokI,TaqI, andBsmI, and their relationship with total vitamin D and cathelicidin levels in ...
Background:Adequate micronutrient absorption remains key for tuberculosis control.Objective:To evaluate the frequency of vitamin D receptor polymorphisms,FokI,TaqI, andBsmI, and their relationship with total vitamin D and cathelicidin levels in ...